American Heart Association Strengthens Board with Key Appointments to Combat Heart Disease and Stroke

The American Heart Association has announced the addition of Dr. Jennifer Ashton and Dr. Joseph Woo to its Board of Directors, effective July 1, 2025. This strategic decision underscores the Association's focus on integrating clinical leadership, health media influence, and scientific innovation to address heart disease and stroke, the foremost causes of mortality in the U.S.

Dr. Ashton, a prominent figure in women's health and ABC News' Chief Medical Correspondent, is set to contribute her profound knowledge in obesity medicine and preventive health. Her ability to demystify complex medical issues and her advocacy for women's cardiovascular health are expected to significantly support the Association's objectives. On the other hand, Dr. Woo, a trailblazer in cardiac surgery and a professor at Stanford Medicine, will bring his wealth of experience in research and clinical trials, particularly in heart failure treatment through cellular repair, to the Board.

Nancy Brown, CEO of the American Heart Association, shared her optimism about the new appointments, emphasizing the distinctive insights both doctors will offer in steering the organization's health transformation initiatives. Their expertise is anticipated to be instrumental in propelling the Association's science-driven strategies and community-focused health solutions forward.

These appointments highlight the American Heart Association's unwavering commitment to improving global health through strategic leadership and partnerships. The Board of Directors is essential in directing the organization's mission to promote longer, healthier lives, with its members acting as key ambassadors to amplify its influence and reach.